双阴性T细胞：移植肿瘤学中一种颇具前景的过继细胞疗法

胡志航; 杨墨丹; 陈昊; 何驰宇; 林祖源; 阳新宇; 李辉港; 沈未; 鲁迪; 徐骁

doi:10.1631/jzus.B2200528

Your Location：

Home >

Browse articles >

双阴性T细胞：移植肿瘤学中一种颇具前景的过继细胞疗法

Scan QR Code

文章被引用时，请邮件提醒。

Submit

Mini-review | Updated：2023-05-15

双阴性T细胞：移植肿瘤学中一种颇具前景的过继细胞疗法
Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology
浙江大学学报（英文版）（B辑：生物医学和生物技术） 2023年24卷第5期页码：387-396
Affiliations：

1.Zhejiang University School of Medicine, Hangzhou 310058, China
2.Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
3.Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou 310006, China
4.Institute of Organ Transplantation, Zhejiang University, Hangzhou 310003, China
5.NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou 310003, China
6.Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou 310004, China
Funds：

the Key Research & Development Plan of Zhejiang Province(2019C03050;2021C03118);the National Key Research and Development Program of China(2021YFA1100500);the National Natural Science Foundation of China(92159202)
DOI：10.1631/jzus.B2200528
中图分类号：
CSTR：
收稿：2022-10-17，

修回：2023-02-19，

纸质出版：2023-05-15
Accepted：

胡志航,杨墨丹,陈昊等.双阴性T细胞：移植肿瘤学中一种颇具前景的过继细胞疗法[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2023,24(05):387-396.

Zhihang HU, Modan YANG, Hao CHEN, et al. Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology[J]. Journal of Zhejiang University-SCIENCE B(Biomedicine & Biotechnology), 2023, 24(5): 387-396.
胡志航,杨墨丹,陈昊等.双阴性T细胞：移植肿瘤学中一种颇具前景的过继细胞疗法[J].浙江大学学报（英文版）（B辑：生物医学和生物技术）,2023,24(05):387-396. DOI： 10.1631/jzus.B2200528.

Zhihang HU, Modan YANG, Hao CHEN, et al. Double-negative T cells: a promising avenue of adoptive cell therapy in transplant oncology[J]. Journal of Zhejiang University-SCIENCE B(Biomedicine & Biotechnology), 2023, 24(5): 387-396. DOI： 10.1631/jzus.B2200528.

摘要

肿瘤复发是肝癌肝移植术后危及生命的主要并发症之一。除了常见的肿瘤复发机制外，另一个不可避免的问题是移植后的免疫抑制治疗方案可能促进肿瘤复发和转移。移植肿瘤学是一个新兴领域以解决肝移植相关的肿瘤学问题。在此背景下，需要综合治疗管理方法来平衡受者的抗肿瘤治疗和免疫抑制状态。双阴性T细胞（DNTs）是一群异质性细胞，主要由T细胞受体（TCR）不同类型的两个亚群组成。其中，TCRαβ

DNTs被认为在免疫性疾病中诱导免疫抑制，而TCRγδ

DNTs被广泛认为是肿瘤杀伤细胞。作为一种复合细胞疗法，健康供体来源的DNTs可在体外增殖至治疗量级，并应用于多种恶性肿瘤的治疗，同时既不损伤正常组织，也不被宿主排斥。本文就DNTs的生物学特性及其在肿瘤学、免疫学和移植领域等方面的研究进展进行综述。基于DNTs的多重作用，我们建议将其作为一种现成的过继性细胞治疗（ACT），从而为移植肿瘤学提供一种新的平衡。

Abstract

Tumor recurrence is one of the major life-threatening complications after liver transplantation for liver cancer. In addition to the common mechanisms underlying tumor recurrence

another unavoidable problem is that the immunosuppressive therapeutic regimen after transplantation could promote tumor recurrence and metastasis. Transplant oncology is an emerging field that addresses oncological challenges in transplantation. In this context

a comprehensive therapeutic management approach is required to balance the anti-tumor treatment and immunosuppressive status of recipients. Double-negative T cells (DNTs) are a cluster of heterogeneous cells mainly consisting of two subsets stratified by T cell receptor (TCR) type. Among them

TCRαβ

DNTs are considered to induce immune suppression in immune-mediated diseases

while TCRγδ

DNTs are widely recognized as tumor killers. As a composite cell therapy

healthy donor-derived DNTs can be propagated to therapeutic numbers in vitro and applied for the treatment of several malignancies without impairing normal tissues or being rejected by the host. In this work

we summarized the biological characteristics and functions of DNTs in oncology

immunology

and transplantation. Based on the multiple roles of DNTs

we propose that a new balance could be achieved in liver transplant oncology using them as an off-the-shelf adoptive cell therapy (ACT).

关键词

Keywords

references

Achita P , Dervovic D , Ly D , et al. , 2018 . Infusion of ex-vivo expanded human TCR-αβ + double-negative regulatory T cells delays onset of xenogeneic graft- versus -host disease . Clin Exp Immunol , 193 ( 3 ): 386 - 399 . https://doi.org/10.1111/cei.13145 https://doi.org/10.1111/cei.13145

Almeida CF , Smith DGM , Cheng TY , et al. , 2021 . Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d . Proc Natl Acad Sci USA , 118 ( 34 ): e2104420118 . https://doi.org/10.1073/PNAS.2104420118 https://doi.org/10.1073/PNAS.2104420118

Bafor EE , Valencia JC , Young HA , 2022 . Double negative T regulatory cells: an emerging paradigm shift in reproductive immune tolerance? Front Immunol , 13 : 886645 . https://doi.org/10.3389/fimmu.2022.886645 https://doi.org/10.3389/fimmu.2022.886645

Broutier L , Mastrogiovanni G , Verstegen MMA , et al. , 2017 . Human primary liver cancer-derived organoid cultures for disease modeling and drug screening . Nat Med , 23 ( 12 ): 1424 - 1435 . https://doi.org/10.1038/nm.4438 https://doi.org/10.1038/nm.4438

Capsomidis A , Benthall G , van Acker HH , et al. , 2018 . Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation . Mol Ther , 26 ( 2 ): 354 - 365 . https://doi.org/10.1016/j.ymthe.2017.12.001 https://doi.org/10.1016/j.ymthe.2017.12.001

Chakraverty R , Teshima T , 2021 . Graft-versus-host disease: a disorder of tissue regeneration and repair . Blood , 138 ( 18 ): 1657 - 1665 . https://doi.org/10.1182/blood.2021011867 https://doi.org/10.1182/blood.2021011867

Chen B , Lee JB , Kang H , et al. , 2018 . Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy . J Exp Clin Cancer Res , 37 : 88 . https://doi.org/10.1186/s13046-018-0756-9 https://doi.org/10.1186/s13046-018-0756-9

Chen J , Hu PB , Wu GH , et al. , 2019 . Antipancreatic cancer effect of DNT cells and the underlying mechanism . Pancreatology , 19 ( 1 ): 105 - 113 . https://doi.org/10.1016/j.pan.2018.12.006 https://doi.org/10.1016/j.pan.2018.12.006

Chen WH , Zhou DJ , Torrealba JR , et al. , 2005 . Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells . J Immunol , 175 ( 5 ): 3409 - 3416 . https://doi.org/10.4049/jimmunol.175.5.3409 https://doi.org/10.4049/jimmunol.175.5.3409

Chowdhary VR , Krogman A , Tilahun AY , et al. , 2017 . Concomitant disruption of CD4 and CD8 genes facilitates the development of double negative αβTCR + peripheral T cells that respond robustly to staphylococcal superantigen . J Immunol , 198 ( 1 ): 4413 - 4424 . https://doi.org/10.4049/jimmunol.1601991 https://doi.org/10.4049/jimmunol.1601991

Crosby CM , Kronenberg M , 2018 . Tissue-specific functions of invariant natural killer T cells . Nat Rev Immunol , 18 ( 9 ): 559 - 574 . https://doi.org/10.1038/s41577-018-0034-2 https://doi.org/10.1038/s41577-018-0034-2

de Gassart A , Le KS , Brune P , et al. , 2021 . Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response . Sci Transl Med , 13 ( 616 ): eabj0835 . https://doi.org/10.1126/scitranslmed.abj0835 https://doi.org/10.1126/scitranslmed.abj0835

Depil S , Duchateau P , Grupp SA , et al. , 2020 . ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges . Nat Rev Drug Discov , 19 ( 3 ): 185 - 199 . https://doi.org/10.1038/s41573-019-0051-2 https://doi.org/10.1038/s41573-019-0051-2

Fang LN , Ly D , Wang SS , et al. , 2019 . Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade . J Exp Clin Cancer Res , 38 : 123 . https://doi.org/10.1186/s13046-019-1126-y https://doi.org/10.1186/s13046-019-1126-y

Fischer K , Voelkl S , Heymann J , et al. , 2005 . Isolation and characterization of human antigen-specific TCRαβ + CD4 - CD8 - double-negative regulatory T cells . Blood , 105 ( 7 ): 2828 - 2835 . https://doi.org/10.1182/blood-2004-07-2583 https://doi.org/10.1182/blood-2004-07-2583

Ford MS , Young KJ , Zhang ZX , et al. , 2002 . The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo . J Exp Med , 196 ( 2 ): 261 - 267 . https://doi.org/10.1084/jem.20020029 https://doi.org/10.1084/jem.20020029

Galluzzi L , Chan TA , Kroemer G , et al. , 2018 . The hallmarks of successful anticancer immunotherapy . Sci Transl Med , 10 ( 459 ): eaat7807 . https://doi.org/10.1126/scitranslmed.aat7807 https://doi.org/10.1126/scitranslmed.aat7807

Gálvez NMS , Bohmwald K , Pacheco GA , et al. , 2021 . Type I natural killer T cells as key regulators of the immune response to infectious diseases . Clin Microbiol Rev , 34 ( 2 ): e00232-20 . https://doi.org/10.1128/CMR.00232-20 https://doi.org/10.1128/CMR.00232-20

Hibi T , Sapisochin G , 2019 . What is transplant oncology? Surgery , 165 ( 2 ): 281 - 285 . https://doi.org/10.1016/j.surg.2018.10.024 https://doi.org/10.1016/j.surg.2018.10.024

Hibi T , Itano O , Shinoda M , et al. , 2017 . Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun . Surg Today , 47 ( 4 ): 403 - 415 . https://doi.org/10.1007/s00595-016-1337-1 https://doi.org/10.1007/s00595-016-1337-1

Hoeres T , Smetak M , Pretscher D , et al. , 2018 . Improving the efficiency of Vγ9Vδ2 T-Cell immunotherapy in cancer . Front Immunol , 9 : 800 . https://doi.org/10.3389/fimmu.2018.00800 https://doi.org/10.3389/fimmu.2018.00800

Hsu J , Krishnan A , Lee SA , et al. , 2021 . CD3 + CD4 - CD8 - double-negative αβ T cells attenuate lung ischemia-reperfusion injury . J Thorac Cardiovasc Surg , 161 ( 1 ): E81 - E90 . https://doi.org/10.1016/j.jtcvs.2019.09.188 https://doi.org/10.1016/j.jtcvs.2019.09.188

Hu SH , Zhang LH , Gao J , et al. , 2021 . NKG2D enhances double-negative T cell regulation of B cells . Front Immunol , 12 : 650788 . https://doi.org/10.3389/fimmu.2021.650788 https://doi.org/10.3389/fimmu.2021.650788

Juvet SC , Zhang L , 2012 . Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions . J Mol Cell Biol , 4 ( 1 ): 48 - 58 . https://doi.org/10.1093/jmcb/mjr043 https://doi.org/10.1093/jmcb/mjr043

Kabelitz D , Serrano R , Kouakanou L , et al. , 2020 . Cancer immunotherapy with γδ T cells: many paths ahead of us . Cell Mol Immunol , 17 ( 9 ): 925 - 939 . https://doi.org/10.1038/s41423-020-0504-x https://doi.org/10.1038/s41423-020-0504-x

Khan AA , Liu ZK , Xu X , 2021 . Recent advances in immunotherapy for hepatocellular carcinoma . Hepatobiliary Pancreat Dis Int , 20 ( 6 ): 511 - 520 . https://doi.org/10.1016/j.hbpd.2021.06.010 https://doi.org/10.1016/j.hbpd.2021.06.010

Kjer-Nielsen L , Corbett AJ , Chen ZJ , et al. , 2018 . An overview on the identification of MAIT cell antigens . Immunol Cell Biol , 96 ( 6 ): 573 - 587 . https://doi.org/10.1111/imcb.12057 https://doi.org/10.1111/imcb.12057

Lee JB , Minden MD , Chen WC , et al. , 2018 . Allogeneic human double negative T cells as a novel immunotherapy for acute myeloid leukemia and its underlying mechanisms . Clin Cancer Res , 24 ( 2 ): 370 - 382 . https://doi.org/10.1158/1078-0432.CCR-17-2228 https://doi.org/10.1158/1078-0432.CCR-17-2228

Lee JB , Kang H , Fang LN , et al. , 2019 . Developing allogeneic double-negative T cells as a novel off-the-shelf adoptive cellular therapy for cancer . Clin Cancer Res , 25 ( 7 ): 2241 - 2253 . https://doi.org/10.1158/1078-0432.CCR-18-2291 https://doi.org/10.1158/1078-0432.CCR-18-2291

Legoux F , Salou M , Lantz O , 2017 . Unconventional or preset αβ T cells: evolutionarily conserved tissue-resident T cells recognizing nonpeptidic ligands . Annu Rev Cell Dev Biol , 33 : 511 - 535 . https://doi.org/10.1146/annurev-cellbio-100616-060725 https://doi.org/10.1146/annurev-cellbio-100616-060725

Ling SB , Zhan QF , Jiang GJ , et al. , 2022 . E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation . Am J Transplant , 22 ( 10 ): 2323 - 2336 . https://doi.org/10.1111/ajt.17124 https://doi.org/10.1111/ajt.17124

Liu YX , Zhang C , 2020 . The role of human γδ T cells in anti-tumor immunity and their potential for cancer immunotherapy . Cells , 9 ( 5 ): 1206 . https://doi.org/10.3390/cells9051206 https://doi.org/10.3390/cells9051206

Lu JQ , Liu JY , Li A , 2022 . Roles of neutrophil reactive oxygen species (ROS) generation in organ function impairment in sepsis . J Zhejiang Univ-Sci B (Biomed & Biotechnol) , 23 ( 6 ): 437 - 450 . https://doi.org/10.1631/jzus.B2101075 https://doi.org/10.1631/jzus.B2101075

Lu Y , Hu PB , Zhou HB , et al. , 2019 . Double-negative T cells inhibit proliferation and invasion of human pancreatic cancer cells in co-culture . Anticancer Res , 39 ( 11 ): 5911 - 5918 . https://doi.org/10.21873/anticanres.13795 https://doi.org/10.21873/anticanres.13795

Marabelle A , Tselikas L , de Baere T , et al. , 2017 . Intratumoral immunotherapy: using the tumor as the remedy . Ann Oncol , 28 : xii33 - xii43 . https://doi.org/10.1093/annonc/mdx683 https://doi.org/10.1093/annonc/mdx683

Mazzaferro V , Regalia E , Doci R , et al. , 1996 . Liver transplantation for the treatment of small hepatocellular carcin omas in patients with cirrhosis. N Engl J Med , 334 ( 11 ): 693 - 700 . https://doi.org/10.1056/NEJM199603143341104 https://doi.org/10.1056/NEJM199603143341104

Merims S , Li X , Joe B , et al. , 2011 . Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy . Leukemia , 25 ( 9 ): 1415 - 1422 . https://doi.org/10.1038/leu.2011.99 https://doi.org/10.1038/leu.2011.99

Mizukoshi E , Kaneko S , 2019 . Immune cell therapy for hepatocellular carcinoma . J Hematol Oncol , 12 : 52 . https://doi.org/10.1186/s13045-019-0742-5 https://doi.org/10.1186/s13045-019-0742-5

Newman-Rivera AM , Kurzhagen JT , Rabb H , 2022 . TCRαβ + CD4 - /CD8 - “double negative” T cells in health and disease-implications for the kidney . Kidney Int , 102 ( 1 ): 25 - 37 . https://doi.org/10.1016/j.kint.2022.02.035 https://doi.org/10.1016/j.kint.2022.02.035

Nordness MF , Hamel S , Godfrey CM , et al. , 2020 . Fatal hep atic necrosis after nivolumab as a bridge to liver transplant for HCC: are checkpoint inhibitors safe for the pretransplant patient? Am J Transplant , 20 ( 3 ): 879 - 883 . https://doi.org/10.1111/ajt.15617 https://doi.org/10.1111/ajt.15617

Pauza CD , Liou ML , Lahusen T , et al. , 2018 . Gamma delta T cell therapy for cancer: it is good to be local . Front Immunol , 9 : 1305 . https://doi.org/10.3389/fimmu.2018.01305 https://doi.org/10.3389/fimmu.2018.01305

Pellicci DG , Uldrich AP , 2018 . Unappreciated diversity within the pool of CD1d-restricted T cells . Semin Cell Dev Biol , 84 : 42 - 47 . https://doi.org/10.1016/j.semcdb.2017.11.031 https://doi.org/10.1016/j.semcdb.2017.11.031

Ponzetta A , Carriero R , Carnevale S , et al. , 2019 . Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors . Cell , 178 ( 2 ): 346 - 360.e24 . https://doi.org/10.1016/j.cell.2019.05.04 https://doi.org/10.1016/j.cell.2019.05.04

Raoul JL , Forner A , Bolondi L , et al. , 2019 . Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence . Cancer Treat Rev , 72 : 28 - 36 . https://doi.org/10.1016/j.ctrv.2018.11.002 https://doi.org/10.1016/j.ctrv.2018.11.002

Ronca V , Wootton G , Milani C , et al. , 2020 . The immunological basis of liver allograft rejection . Front Immunol , 11 : 2155 . https://doi.org/10.3389/fimmu.2020.02155 https://doi.org/10.3389/fimmu.2020.02155

Soares F , Chen B , Lee JB , et al. , 2021 . CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy . Blood , 137 ( 16 ): 2171 - 2181 . https://doi.org/10.1182/blood.2019004108 https://doi.org/10.1182/blood.2019004108

Strippoli S , Fanizzi A , Negri A , et al. , 2021 . Examining the relationship between circulating CD4 - CD8 - double-negative T cells and outcomes of immuno-checkpoint inhibitor therapy—looking for biomarkers and therapeutic targets in metastatic melanoma . Cells , 10 ( 2 ): 406 . https://doi.org/10.3390/cells10020406 https://doi.org/10.3390/cells10020406

Sun H , Cao S , Mashl RJ , et al. , 2021 . Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment . Nat Commun , 12 : 5086 . https://doi.org/10.1038/s41467-021-25177-3 https://doi.org/10.1038/s41467-021-25177-3

Takada Y , Ito T , Ueda M , et al. , 2007 . Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria . Dig Dis , 25 ( 4 ): 299 - 302 . https://doi.org/10.1159/000106908 https://doi.org/10.1159/000106908

Thommen DS , Schumacher TN , 2018 . T cell dysfunction in cancer . Cancer Cell , 33 ( 4 ): 547 - 562 . https://doi.org/10.1016/j.ccell.2018.03.012 https://doi.org/10.1016/j.ccell.2018.03.012

Tuveson D , Clevers H , 2019 . Cancer modeling meets human organoid technology . Science , 364 ( 6444 ): 952 - 955 . https://doi.org/10.1126/science.aaw6985 https://doi.org/10.1126/science.aaw6985

Vasic D , Lee JB , Leung Y , et al. , 2022 . Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities . Sci Immunol , 7 ( 70 ): eabl3642 . https://doi.org/10.1126/sciimmunol.abl3642 https://doi.org/10.1126/sciimmunol.abl3642

Velikkakam T , Gollob KJ , Dutra WO , 2022 . Double-negative T cells: setting the stage for disease control or progression . Immunology , 165 ( 4 ): 371 - 385 . https://doi.org/10.1111/imm.13441 https://doi.org/10.1111/imm.13441

Verna EC , Patel YA , Aggarwal A , et al. , 2020 . Liver transplantation for hepatocellular carcinoma: management after the transplant . Am J Transplant , 20 ( 2 ): 333 - 347 . https://doi.org/10.1111/ajt.15697 https://doi.org/10.1111/ajt.15697

Voelkl S , Moore TV , Rehli M , et al. , 2009 . Characterization of MHC class-I restricted TCRαβ + CD4 - CD8 - double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination . Cancer Immunol Immunother , 58 ( 5 ): 709 - 718 . https://doi.org/10.1007/s00262-008-0593-3 https://doi.org/10.1007/s00262-008-0593-3

Xu H , Zhu XX , Chen J , 2016 . DNT cell inhibits the growth of pancreatic carcinoma via abnormal expressions of NKG2D and MICA in vivo . Biochem Biophys Res Commun , 469 ( 2 ): 145 - 150 . https://doi.org/10.1016/j.bbrc.2015.11.085 https://doi.org/10.1016/j.bbrc.2015.11.085

Xu X , Lu D , Ling Q , et al. , 2016 . Liver transplantation for hepatocellular carcinoma beyond the Milan criteria . Gut , 65 ( 6 ): 1035 - 1041 . https://doi.org/10.1136/gutjnl-2014-308513 https://doi.org/10.1136/gutjnl-2014-308513

Yang XY , Lu D , Wang R , et al. , 2021 . Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation . Cell Prolif , 54 ( 10 ): e13116 . https://doi.org/10.1111/CPR.13116 https://doi.org/10.1111/CPR.13116

Yao FY , Ferrell L , Bass NM , et al. , 2001 . Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival . Hepatology , 33 ( 6 ): 1394 - 1403 . https://doi.org/10.1053/jhep.2001.24563 https://doi.org/10.1053/jhep.2001.24563

Yao JL , Ly D , Dervovic D , et al. , 2019 . Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15 . J Immunother Cancer , 7 ( 1 ): 17 . https://doi.org/10.1186/s40425-019-0507-2 https://doi.org/10.1186/s40425-019-0507-2

Ye QW , Ling SB , Zheng SS , et al. , 2019 . Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circu lating tumor DNA. Mol Cancer , 18 : 114 . https://doi.org/10.1186/s12943-019-1043-x https://doi.org/10.1186/s12943-019-1043-x

Young KJ , Yang LM , Phillips MJ , et al. , 2002 . Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells . Blood , 100 ( 9 ): 3408 - 3414 . https://doi.org/10.1182/blood-2002-01-0235 https://doi.org/10.1182/blood-2002-01-0235

Young KJ , Kay LS , Phillips MJ , et al. , 2003 . Antitumor activity mediated by double-negative T cells . Cancer Res , 63 ( 22 ): 8014 - 8021 .

Zhang YJ , Kong DR , Wang H , 2020 . Mucosal-associated invariant T cell in liver diseases . Int J Biol Sci , 16 ( 3 ): 460 - 470 . https://doi.org/10.7150/ijbs.39016 https://doi.org/10.7150/ijbs.39016

Zhuo JY , Su RY , Tan WY , et al. , 2020 . The ongoing trends of patient-derived xenograft models in oncology . Cancer Commun (Lond) , 40 ( 11 ): 559 - 563 . https://doi.org/10.1002/cac2.12096 https://doi.org/10.1002/cac2.12096

浏览量

Downloads

CSCD

工具集

关联资源

Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook

Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation

Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation

SCMG对煤和蒙脱石浮选分离的影响

热轧板带凸度影响因素的敏感性分析